Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-03-06 4:28 pm Purchase | 2026-03-04 | 13D | Tyra Biosciences, Inc. TYRA | RA Capital Management, L.P. | 12,266,575 21.200% | 366,787 (+3.08%) | Filing History |
| 2026-02-20 08:14 am Purchase | 2026-02-12 | 13G | Tyra Biosciences, Inc. TYRA | Farallon Capital Partners, L.P. | 2,984,818 5.600% | 2,984,818 (New Position) | Filing History |
| 2026-02-17 4:28 pm Sale | 2025-12-31 | 13G | Tyra Biosciences, Inc. TYRA | BIOTECHNOLOGY VALUE FUND L P | 2,127,665 4.000% | -1,816,529 (-46.06%) | Filing History |
| 2026-02-13 4:30 pm Purchase | 2025-12-31 | 13G | Tyra Biosciences, Inc. TYRA | Harris Todd | 2,814,379 5.100% | 2,814,379 (New Position) | Filing History |
| 2026-02-13 4:15 pm Sale | 2025-12-31 | 13G | Tyra Biosciences, Inc. TYRA | Canaan XI L.P. | 2,930,444 5.500% | -800,721 (-21.46%) | Filing History |
| 2025-11-14 4:35 pm Purchase | 2025-09-30 | 13G | Tyra Biosciences, Inc. TYRA | Commodore Capital LP | 3,375,000 6.300% | 625,000 (+22.73%) | Filing History |
| 2025-11-14 4:02 pm Sale | 2025-09-30 | 13G | Tyra Biosciences, Inc. TYRA | Vestal Point Capital, LP | 2,425,000 4.500% | -454,829 (-15.79%) | Filing History |
| 2025-08-14 11:44 am Purchase | 2025-06-30 | 13G | Tyra Biosciences, Inc. TYRA | JANUS HENDERSON GROUP PLC JHG | 2,856,290 5.400% | 163,053 (+6.05%) | Filing History |
| 2025-06-06 4:50 pm Purchase | 2025-06-04 | 13D | Tyra Biosciences, Inc. TYRA | RA Capital Management, L.P. | 11,899,788 22.400% | 1,214,898 (+11.37%) | Filing History |
| 2025-05-15 4:14 pm Purchase | 2025-03-31 | 13G | Tyra Biosciences, Inc. TYRA | Vestal Point Capital, LP | 2,879,829 5.400% | 2,879,829 (New Position) | Filing History |
| 2025-05-14 4:05 pm Purchase | 2025-05-07 | 13G | Tyra Biosciences, Inc. TYRA | Commodore Capital LP | 2,750,000 5.200% | 2,750,000 (New Position) | Filing History |
| 2025-05-14 11:47 am Purchase | 2025-03-31 | 13G | Tyra Biosciences, Inc. TYRA | JANUS HENDERSON GROUP PLC JHG | 2,693,237 5.100% | 2,693,237 (New Position) | Filing History |
| 2025-05-12 10:43 am Sale | 2025-03-31 | 13G | Tyra Biosciences, Inc. TYRA | FMR LLC | 1,707,148 3.200% | -1,665,702 (-49.39%) | Filing History |
| 2025-03-31 4:54 pm Purchase | 2025-03-27 | 13D | Tyra Biosciences, Inc. TYRA | RA Capital Management, L.P. | 10,684,890 20.100% | 7,750 (+0.07%) | Filing History |
| 2025-03-06 6:02 pm Purchase | 2025-02-27 | 13G | Tyra Biosciences, Inc. TYRA | TCG Crossover GP I, LLC | 2,898,103 5.700% | 2,898,103 (New Position) | Filing History |
| 2025-02-14 4:24 pm Sale | 2024-12-31 | 13G | Tyra Biosciences, Inc. TYRA | BIOTECHNOLOGY VALUE FUND L P | 3,944,194 7.800% | -717,000 (-15.38%) | Filing History |
| 2025-01-21 4:30 pm Sale | 2024-12-31 | 13G | Tyra Biosciences, Inc. TYRA | Canaan XI L.P. | 3,731,165 7.400% | -205,430 (-5.22%) | Filing History |
| 2024-12-06 9:30 pm Sale | 2024-12-04 | 13D | Tyra Biosciences, Inc. TYRA | Boxer Capital Management LLC | 2,548,905 5.000% | -1,522,949 (-37.40%) | Filing History |
| 2024-11-19 9:31 pm Sale | 2024-11-15 | 13D | Tyra Biosciences, Inc. TYRA | Boxer Capital Management LLC | 4,071,854 7.700% | -914,461 (-18.34%) | Filing History |
| 2024-11-14 5:47 pm Purchase | 2024-09-30 | 13G | Tyra Biosciences, Inc. TYRA | NEXTECH VI ONCOLOGY SCSP | 4,055,861 7.700% | 1,537,279 (+61.04%) | Filing History |